Aim-To assess prospectively the value of three serological tests for differentiating between ulcerative colitis and Crohn's disease, used either alone or combined. Methods-Coded serum samples from 63 patients with ulcerative colitis and 67 patients with Crohn's disease were analysed. Detection assays for the presence of perinuclear antineutrophil cytoplasmic antibodies (pANCA), serum agglutinating antibodies to anaerobic coccoid rods, and specific IgG antibodies against a Kd-45/48 immunological crossreactive mycobacterial antigen complex (ImCrAC) were studied. Sensitivity, specificity, preand post-test probabilities, likelihood ratios, and predictive values of each of these serological tests were determined. Results-The sensitivity and specificity of the pANCA test for the diagnosis of ulcerative colitis were 61 and 79%, respectively. The serum agglutination test for anaerobic coccoid rods had a sensitivity of 42% and a specificity of 89% for a
gest that these are different diseases.1" A search for serological tests to differentiate between ulcerative colitis and Crohn's disease has been underway since the 1950s.34 An ideal serological marker should meet the following criteria: the test should be positive in most patients suffering from the disease (high sensitivity) and only be present in that particular disease (high specificity). A marker with these features offers a high positive likelihood ratio for disease and optimal possibilities as a screening assay. The predictive value for disease using such a test would be high and a negative test result would suggest that a patient is not suffering from the disease.
Since 1990, perinuclear antineutrophil cytoplasmic antibodies (pANCA) have been consistently found in patients with ulcerative colitis.56 Another possible useful test for the diagnosis of ulcerative colitis is based on the detection of autoantibodies against a Kd-40 protein, which appears to be specific for ulcerative colitis and primary sclerosing cholangitis.78 This test, however, is not widely available.
In Crohn's disease, patients with antibodies to intestinal bacteria9 and elevated antibody titres against different food antigens have been described. ' doublet.'7 These common antigens were derived from three mycobacterial strains: Mycobacterium avium, M tuberculosis and M paratuberculosis. Serum samples were added to precoated wells containing the Kd-45/48 antigen and then incubated with peroxidase labelled antihuman IgG antibodies. Subsequently, the peroxidase reaction was carried out with hydrogen peroxide and 2,2,4,4 tetramethyl benzidine. Optimal density was measured using a spectrophotometer at 450nm. On a scale from 0 00 to 2-00, <0.5 was considered negative and >0 5 positive.
STATISTICS
Sensitivity was defined as the probability of a positive test result in a patient with the disease under investigation. Specificity was defined as the probability of having a negative result in a patient without the disease under investigation. Pretest probability is the probability of disease in the patient to be tested. Pretest odds is the odds ofhaving the disease and can be calculated by dividing the pretest probability by 1 minus the pretest probability.
The likelihood ratio is a measure of the validity of a test, given its sensitivity and specificity. It was calculated as the ratio of the probability of getting a result in patients with the condition of interest to the probability of getting that same result in patients without that condition.
Predictive values were calculated for each of the test results. The predictive value of a test result is the probability of a true test result in the patients with a given test result. The predictive value depends on the pretest probability and can be determined from the formula based on the Bayes theorem of conditional probability. 23 Post-test probability is the probability of disease in a patient with a given test result. Aggl-= absence of serum agglutinating antibodies to anaerobic coccoid rods; * corrected for convergence where necessary. 30-53'6 ) and a specificity of 89% (95% CI 81-1-96 6), which corresponds to a positive likelihood ratio of 3-6 (95% CI 1-7-7-7). The post-test probability curve for a diagnosis of Crohn's disease after the agglutination test was 80% ( figure) . The relation between pre-and post-test probabilities for the three different tests.
giving a sensitivity of 70% (95% CI 59-2-81-1), a specificity of 60% (95% CI 48-2-72A4), and a positive likelihood ratio of 17 (95% CI 1-2-2A4). The post-test probability for a diagnosis of Crohn's disease after testing for ImCrAC was 65% ( figure) . The agglutination test for Crohn's disease and the pANCA test for ulcerative colitis showed the highest predictive values and likelihood ratios. In ulcerative colitis, starting with a positive pANCA result, the combination of all tests had a lower likelihood ratio than when just the pANCA and ImCrAC sets were combined (table 1) . A small subgroup of patients with Crohn's disease (n = 20) could be defined with 100% specificity when both the serum agglutination and ImCrAC tests were positive and the pANCA test negative (table 2) .
Discussion
In the present study, we assessed the value of three serological tests for differentiating between ulcerative colitis and Crohn's disease. At present, it appears that only the pANCA test may be of diagnostic value with reproducible results.5 6 24 25 Only 61% of serum samples from patients with ulcerative colitis were positive for the presence of pANCA (table 1); this was in contrast to the 79% pANCA positivity demonstrated previously in a much larger study by our group.6 However, the results of the present study are still comparable to the incidence figures obtained in western Europe, as analysed recently. 26 To date, no major progress in the localisation of the pANCA antigen has been made2728; it is therefore almost impossible to characterise pANCA positive or negative patients more accurately. The observed differences in pANCA prevalence in this and in previous studies in our region may be attributed to the inclusion of different patient subpopulations (see later). In conclusion, the present study has clearly shown that use of the available serological tests, either singly or combined, does not aid diagnosis. However, a positive pANCA response is of value in establishing a diagnosis of ulcerative colitis. The hypothesis that the above antibodies are markers of subgroups of IBD is highly attractive and should be pursued vigorously. The elucidation of the influence of genetic factors on the immune system, and the definition of patient subgroups by serological and genetic markers will be a major diagnostic research project, eventually resulting in a better insight into the behaviour of IBD in the respective disease subgroups.
